

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 4.35586244 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.24420378 |
| 3 | plasma membrane repair (GO:0001778) | 4.23717580 |
| 4 | regulation of relaxation of muscle (GO:1901077) | 4.09439402 |
| 5 | cardiac myofibril assembly (GO:0055003) | 4.08241888 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.03807738 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95286641 |
| 8 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.87357075 |
| 9 | skeletal muscle adaptation (GO:0043501) | 3.84104821 |
| 10 | response to inactivity (GO:0014854) | 3.82658877 |
| 11 | cell communication involved in cardiac conduction (GO:0086065) | 3.73202671 |
| 12 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.73120970 |
| 13 | myofibril assembly (GO:0030239) | 3.71564471 |
| 14 | muscle filament sliding (GO:0030049) | 3.71488230 |
| 15 | actin-myosin filament sliding (GO:0033275) | 3.71488230 |
| 16 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.59358755 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.57150899 |
| 18 | mannose metabolic process (GO:0006013) | 3.53733510 |
| 19 | cardiac muscle contraction (GO:0060048) | 3.46665583 |
| 20 | carnitine shuttle (GO:0006853) | 3.46010975 |
| 21 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.33904569 |
| 22 | positive regulation of myotube differentiation (GO:0010831) | 3.32252320 |
| 23 | striated muscle atrophy (GO:0014891) | 3.29382187 |
| 24 | cell communication by electrical coupling (GO:0010644) | 3.24361509 |
| 25 | lysine catabolic process (GO:0006554) | 3.24148863 |
| 26 | lysine metabolic process (GO:0006553) | 3.24148863 |
| 27 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.17407947 |
| 28 | regulation of skeletal muscle contraction (GO:0014819) | 3.16935238 |
| 29 | fatty acid transmembrane transport (GO:1902001) | 3.16142778 |
| 30 | actin-mediated cell contraction (GO:0070252) | 3.13405920 |
| 31 | response to muscle activity (GO:0014850) | 3.13217515 |
| 32 | muscle contraction (GO:0006936) | 3.12914739 |
| 33 | negative regulation of myotube differentiation (GO:0010832) | 3.09148312 |
| 34 | * actomyosin structure organization (GO:0031032) | 3.08824183 |
| 35 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.07122212 |
| 36 | skeletal muscle fiber development (GO:0048741) | 3.03402990 |
| 37 | striated muscle contraction (GO:0006941) | 3.02915722 |
| 38 | regulation of actin filament-based movement (GO:1903115) | 3.02051069 |
| 39 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.00154706 |
| 40 | regulation of membrane repolarization (GO:0060306) | 2.92778226 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 2.92535380 |
| 42 | glycogen catabolic process (GO:0005980) | 2.91677440 |
| 43 | NADH metabolic process (GO:0006734) | 2.90857734 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 2.90228592 |
| 45 | negative regulation of necroptotic process (GO:0060546) | 2.86789912 |
| 46 | creatine metabolic process (GO:0006600) | 2.85596848 |
| 47 | muscle system process (GO:0003012) | 2.85489730 |
| 48 | actin filament-based movement (GO:0030048) | 2.84088276 |
| 49 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.83675071 |
| 50 | striated muscle hypertrophy (GO:0014897) | 2.80627904 |
| 51 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.80378932 |
| 52 | cardiac conduction (GO:0061337) | 2.79776098 |
| 53 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75669449 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75633165 |
| 55 | desmosome organization (GO:0002934) | 2.75558208 |
| 56 | muscle adaptation (GO:0043500) | 2.74346677 |
| 57 | cell-substrate adherens junction assembly (GO:0007045) | 2.73950245 |
| 58 | focal adhesion assembly (GO:0048041) | 2.73950245 |
| 59 | germinal center formation (GO:0002467) | 2.73199098 |
| 60 | regulation of necroptotic process (GO:0060544) | 2.73037560 |
| 61 | adult heart development (GO:0007512) | 2.71915347 |
| 62 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.71877267 |
| 63 | sodium ion export (GO:0071436) | 2.69383983 |
| 64 | cellular polysaccharide catabolic process (GO:0044247) | 2.68529222 |
| 65 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.66746543 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.65518404 |
| 67 | carnitine transport (GO:0015879) | 2.64065269 |
| 68 | amino-acid betaine transport (GO:0015838) | 2.64065269 |
| 69 | carnitine transmembrane transport (GO:1902603) | 2.63668283 |
| 70 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.62985738 |
| 71 | cardiac muscle cell action potential (GO:0086001) | 2.62235301 |
| 72 | muscle atrophy (GO:0014889) | 2.61605848 |
| 73 | cardiac muscle cell development (GO:0055013) | 2.61423695 |
| 74 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.59959149 |
| 75 | muscle tissue morphogenesis (GO:0060415) | 2.57792245 |
| 76 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.54082658 |
| 77 | myotube cell development (GO:0014904) | 2.54081309 |
| 78 | regulation of striated muscle contraction (GO:0006942) | 2.52648237 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 2.52288888 |
| 80 | cellular response to epinephrine stimulus (GO:0071872) | 2.50910057 |
| 81 | regulation of the force of heart contraction (GO:0002026) | 2.50175247 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 2.49904474 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 2.48472569 |
| 84 | regulation of p38MAPK cascade (GO:1900744) | 2.48179467 |
| 85 | potassium ion import (GO:0010107) | 2.47718746 |
| 86 | cardiac cell development (GO:0055006) | 2.47687058 |
| 87 | cardiac muscle adaptation (GO:0014887) | 2.46751273 |
| 88 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.46751273 |
| 89 | muscle hypertrophy in response to stress (GO:0003299) | 2.46751273 |
| 90 | skeletal muscle tissue development (GO:0007519) | 2.45822036 |
| 91 | cell-substrate junction assembly (GO:0007044) | 2.44370167 |
| 92 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.44150555 |
| 93 | tricarboxylic acid cycle (GO:0006099) | 2.43523003 |
| 94 | adherens junction assembly (GO:0034333) | 2.42830699 |
| 95 | skeletal muscle contraction (GO:0003009) | 2.42253445 |
| 96 | negative regulation of necrotic cell death (GO:0060547) | 2.41903962 |
| 97 | activation of protein kinase A activity (GO:0034199) | 2.40682530 |
| 98 | phospholipid homeostasis (GO:0055091) | 2.40326453 |
| 99 | regulation of myotube differentiation (GO:0010830) | 2.39602345 |
| 100 | regulation of fatty acid oxidation (GO:0046320) | 2.37759409 |
| 101 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.37758721 |
| 102 | relaxation of cardiac muscle (GO:0055119) | 2.37224680 |
| 103 | muscle hypertrophy (GO:0014896) | 2.36850687 |
| 104 | positive regulation of Rap GTPase activity (GO:0032854) | 2.36104284 |
| 105 | protein localization to endosome (GO:0036010) | 2.36054823 |
| 106 | heart trabecula formation (GO:0060347) | 2.35841014 |
| 107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.35624756 |
| 108 | polysaccharide catabolic process (GO:0000272) | 2.35333708 |
| 109 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.34991761 |
| 110 | membrane tubulation (GO:0097320) | 2.33360975 |
| 111 | membrane repolarization during action potential (GO:0086011) | 2.32924999 |
| 112 | regulation of cell communication by electrical coupling (GO:0010649) | 2.32206235 |
| 113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.32115288 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.31815443 |
| 115 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.30510765 |
| 116 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.30510765 |
| 117 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.30205276 |
| 118 | negative regulation of protein localization to cell surface (GO:2000009) | 2.29754876 |
| 119 | striated muscle adaptation (GO:0014888) | 2.29746240 |
| 120 | regulation of myoblast differentiation (GO:0045661) | 2.29558826 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 2.29507850 |
| 122 | positive thymic T cell selection (GO:0045059) | 2.29032035 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.28787050 |
| 124 | L-phenylalanine catabolic process (GO:0006559) | 2.28787050 |
| 125 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.27035358 |
| 126 | positive regulation of myoblast differentiation (GO:0045663) | 2.26980486 |
| 127 | cellular hyperosmotic response (GO:0071474) | 2.26218037 |
| 128 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.25851290 |
| 129 | hemidesmosome assembly (GO:0031581) | 2.25824904 |
| 130 | regulation of sarcomere organization (GO:0060297) | 2.25725645 |
| 131 | fatty acid beta-oxidation (GO:0006635) | 2.25710527 |
| 132 | acetyl-CoA metabolic process (GO:0006084) | 2.25697904 |
| 133 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.23550755 |
| 134 | fructose metabolic process (GO:0006000) | 2.23521911 |
| 135 | negative regulation of cell size (GO:0045792) | 2.22959399 |
| 136 | glyoxylate metabolic process (GO:0046487) | 2.22397405 |
| 137 | regulation of synapse structural plasticity (GO:0051823) | 2.22376397 |
| 138 | response to mercury ion (GO:0046689) | 2.21495613 |
| 139 | response to epinephrine (GO:0071871) | 2.21037635 |
| 140 | regulation of cardioblast differentiation (GO:0051890) | 2.20841366 |
| 141 | regulation of gamma-delta T cell activation (GO:0046643) | 2.20534711 |
| 142 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.20527231 |
| 143 | response to muramyl dipeptide (GO:0032495) | 2.20262750 |
| 144 | glucan catabolic process (GO:0009251) | 2.20208706 |
| 145 | negative regulation of potassium ion transport (GO:0043267) | 2.20204309 |
| 146 | kynurenine metabolic process (GO:0070189) | 2.20074389 |
| 147 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.19662725 |
| 148 | positive regulation of cation channel activity (GO:2001259) | 2.19065087 |
| 149 | muscle fiber development (GO:0048747) | 2.18552040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.18299209 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.92570364 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45892898 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32236700 |
| 5 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.30007518 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.23564977 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.23063976 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22429382 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.12279410 |
| 10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.11655585 |
| 11 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07246024 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01609357 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.00489289 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.86523246 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82097241 |
| 16 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.81948856 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81918373 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.81762669 |
| 19 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.77355848 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70350552 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69343830 |
| 22 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.68613644 |
| 23 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.65876298 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.65876298 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64441355 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64046529 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60758420 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55774428 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54929887 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54929887 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.53044314 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52438052 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.50298818 |
| 34 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49855044 |
| 35 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.48572173 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46161792 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.43584010 |
| 38 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43537734 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43347973 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42333656 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41570800 |
| 42 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38622708 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38441106 |
| 44 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38356543 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38317989 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37707400 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.37394497 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36783340 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.36448299 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36082927 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34165849 |
| 52 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.33604021 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32659908 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.31669969 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31441191 |
| 56 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31329314 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30276145 |
| 58 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29623662 |
| 59 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29113530 |
| 60 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28693992 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27820937 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27786530 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26214813 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25346673 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25257297 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24023966 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23783365 |
| 68 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23614685 |
| 69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23418934 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23171060 |
| 71 | * P68_20966046_ChIP-Seq_HELA_Human | 1.21324422 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21262344 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21006704 |
| 74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20657172 |
| 75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20617823 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20067123 |
| 77 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20020834 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19939427 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19283852 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17778341 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17509334 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17414888 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17082820 |
| 84 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16755559 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16586818 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16290323 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15394200 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15034118 |
| 89 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13809838 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13581387 |
| 91 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13157301 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12399274 |
| 93 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11170035 |
| 94 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11023409 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10879231 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10844919 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10701666 |
| 98 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09245822 |
| 99 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09073663 |
| 100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08850041 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08101826 |
| 102 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.08088354 |
| 103 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07432099 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06910139 |
| 105 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06536634 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04771120 |
| 107 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04470702 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03221820 |
| 109 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03161613 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.02967377 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02166712 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02070768 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01318544 |
| 114 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01195838 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00602282 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98892933 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98824804 |
| 118 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98573348 |
| 119 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98509458 |
| 120 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98479352 |
| 121 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97959686 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97801420 |
| 123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97682279 |
| 124 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97475302 |
| 125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96583286 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95781080 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95321344 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95233750 |
| 129 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94522941 |
| 130 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92847183 |
| 131 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92811479 |
| 132 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92497755 |
| 133 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90274406 |
| 134 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89753807 |
| 135 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89590394 |
| 136 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88688149 |
| 137 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87063161 |
| 138 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87040098 |
| 139 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87032663 |
| 140 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.86976298 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85633078 |
| 142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84674370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.23814489 |
| 2 | MP0000751_myopathy | 3.95704823 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.51782710 |
| 4 | MP0005360_urolithiasis | 3.19148843 |
| 5 | MP0004036_abnormal_muscle_relaxation | 2.89513508 |
| 6 | MP0003646_muscle_fatigue | 2.81218005 |
| 7 | MP0000749_muscle_degeneration | 2.76017058 |
| 8 | MP0004215_abnormal_myocardial_fiber | 2.66921153 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.65360848 |
| 10 | MP0005330_cardiomyopathy | 2.48706129 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.44825356 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.39917431 |
| 13 | MP0004130_abnormal_muscle_cell | 2.23261655 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.16287117 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 2.09651582 |
| 16 | MP0005409_darkened_coat_color | 2.08368754 |
| 17 | MP0003252_abnormal_bile_duct | 2.06851410 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.03659905 |
| 19 | MP0000747_muscle_weakness | 2.01805918 |
| 20 | MP0005365_abnormal_bile_salt | 1.98526844 |
| 21 | MP0002332_abnormal_exercise_endurance | 1.97702053 |
| 22 | MP0002972_abnormal_cardiac_muscle | 1.97073765 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.96840663 |
| 24 | MP0005620_abnormal_muscle_contractility | 1.92294284 |
| 25 | MP0002269_muscular_atrophy | 1.84143488 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.78942893 |
| 27 | MP0003137_abnormal_impulse_conducting | 1.78215128 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.75968155 |
| 29 | MP0002106_abnormal_muscle_physiology | 1.73900210 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.71764078 |
| 31 | MP0006138_congestive_heart_failure | 1.64587435 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.59629237 |
| 33 | MP0004270_analgesia | 1.56017759 |
| 34 | MP0005083_abnormal_biliary_tract | 1.55481524 |
| 35 | MP0004085_abnormal_heartbeat | 1.54962921 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.54929134 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.54929134 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.53823509 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.53342705 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.48133875 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47379310 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.47244884 |
| 43 | MP0000759_abnormal_skeletal_muscle | 1.45673567 |
| 44 | MP0004484_altered_response_of | 1.44208889 |
| 45 | MP0002822_catalepsy | 1.43030916 |
| 46 | MP0005369_muscle_phenotype | 1.42102511 |
| 47 | MP0009840_abnormal_foam_cell | 1.40576330 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.38762122 |
| 49 | MP0003329_amyloid_beta_deposits | 1.36805379 |
| 50 | MP0009278_abnormal_bone_marrow | 1.36110480 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.35239887 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.31517447 |
| 53 | MP0003303_peritoneal_inflammation | 1.26901399 |
| 54 | MP0003195_calcinosis | 1.26633247 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.25867787 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.25039176 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.22327048 |
| 58 | MP0004233_abnormal_muscle_weight | 1.22068792 |
| 59 | MP0002796_impaired_skin_barrier | 1.21962574 |
| 60 | MP0003436_decreased_susceptibility_to | 1.21942069 |
| 61 | MP0004510_myositis | 1.21298284 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.18501599 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.17070474 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.15416553 |
| 65 | MP0004858_abnormal_nervous_system | 1.13979029 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.12301270 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.11533277 |
| 68 | MP0004043_abnormal_pH_regulation | 1.09749032 |
| 69 | MP0005451_abnormal_body_composition | 1.08483937 |
| 70 | MP0005332_abnormal_amino_acid | 1.07491225 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.06202858 |
| 72 | MP0003879_abnormal_hair_cell | 1.06117180 |
| 73 | MP0008260_abnormal_autophagy | 1.04351388 |
| 74 | MP0000579_abnormal_nail_morphology | 1.03487125 |
| 75 | MP0004947_skin_inflammation | 1.01946175 |
| 76 | MP0005670_abnormal_white_adipose | 1.01604002 |
| 77 | MP0003045_fibrosis | 1.01586577 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.01137470 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.98220014 |
| 80 | MP0003091_abnormal_cell_migration | 0.97742896 |
| 81 | MP0005464_abnormal_platelet_physiology | 0.96101090 |
| 82 | MP0000733_abnormal_muscle_development | 0.92083836 |
| 83 | MP0003283_abnormal_digestive_organ | 0.91591296 |
| 84 | MP0003690_abnormal_glial_cell | 0.90904049 |
| 85 | MP0003279_aneurysm | 0.90169052 |
| 86 | MP0003950_abnormal_plasma_membrane | 0.89769933 |
| 87 | MP0004381_abnormal_hair_follicle | 0.88848695 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 0.88376710 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.87556635 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.87251993 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.83910394 |
| 92 | MP0010678_abnormal_skin_adnexa | 0.83390661 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.82576561 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82326691 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.82236027 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.80689277 |
| 97 | MP0005187_abnormal_penis_morphology | 0.80569631 |
| 98 | MP0003828_pulmonary_edema | 0.80023096 |
| 99 | MP0004272_abnormal_basement_membrane | 0.78846528 |
| 100 | MP0005166_decreased_susceptibility_to | 0.78266488 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.75430310 |
| 102 | MP0001958_emphysema | 0.75064277 |
| 103 | MP0002419_abnormal_innate_immunity | 0.74889071 |
| 104 | MP0000685_abnormal_immune_system | 0.74784866 |
| 105 | MP0000604_amyloidosis | 0.74369522 |
| 106 | MP0002971_abnormal_brown_adipose | 0.73992444 |
| 107 | MP0001661_extended_life_span | 0.73662938 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.72000604 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.71088726 |
| 110 | MP0004885_abnormal_endolymph | 0.70873804 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.70577381 |
| 112 | MP0002254_reproductive_system_inflammat | 0.69040829 |
| 113 | MP0008874_decreased_physiological_sensi | 0.68457306 |
| 114 | MP0001849_ear_inflammation | 0.67570061 |
| 115 | MP0002127_abnormal_cardiovascular_syste | 0.67397396 |
| 116 | MP0005025_abnormal_response_to | 0.67301800 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.66982992 |
| 118 | MP0000266_abnormal_heart_morphology | 0.66980336 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.66915984 |
| 120 | MP0005397_hematopoietic_system_phenotyp | 0.66915984 |
| 121 | MP0003075_altered_response_to | 0.65701280 |
| 122 | MP0005275_abnormal_skin_tensile | 0.65694850 |
| 123 | MP0008569_lethality_at_weaning | 0.65472294 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64995293 |
| 125 | MP0009643_abnormal_urine_homeostasis | 0.64883567 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.64842187 |
| 127 | MP0000920_abnormal_myelination | 0.63972077 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.63579016 |
| 129 | MP0000609_abnormal_liver_physiology | 0.63071513 |
| 130 | MP0001851_eye_inflammation | 0.62700210 |
| 131 | MP0005266_abnormal_metabolism | 0.62668089 |
| 132 | MP0001790_abnormal_immune_system | 0.60347636 |
| 133 | MP0005387_immune_system_phenotype | 0.60347636 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 0.59876906 |
| 135 | MP0009115_abnormal_fat_cell | 0.59266462 |
| 136 | MP0002249_abnormal_larynx_morphology | 0.57812345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.42602767 |
| 2 | Hyporeflexia of lower limbs (HP:0002600) | 4.71147815 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 4.55069237 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.54048763 |
| 5 | Muscle fiber splitting (HP:0003555) | 4.17931782 |
| 6 | Ventricular tachycardia (HP:0004756) | 4.17302649 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 3.95243795 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 3.91608148 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 3.67363455 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.66932801 |
| 11 | Difficulty running (HP:0009046) | 3.59775246 |
| 12 | Bundle branch block (HP:0011710) | 3.51974873 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 3.49360755 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 3.46810725 |
| 15 | Syncope (HP:0001279) | 3.44976394 |
| 16 | Atrial fibrillation (HP:0005110) | 3.44059175 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 3.40672020 |
| 18 | Ventricular fibrillation (HP:0001663) | 3.39636547 |
| 19 | Subaortic stenosis (HP:0001682) | 3.31337061 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.31337061 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 3.21959328 |
| 22 | Increased connective tissue (HP:0009025) | 3.21591675 |
| 23 | Prolonged QT interval (HP:0001657) | 3.19958473 |
| 24 | Myoglobinuria (HP:0002913) | 3.09008345 |
| 25 | Ventricular arrhythmia (HP:0004308) | 3.03569695 |
| 26 | Supraventricular tachycardia (HP:0004755) | 2.99985134 |
| 27 | Supraventricular arrhythmia (HP:0005115) | 2.99785947 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 2.91992452 |
| 29 | Muscle fiber inclusion bodies (HP:0100299) | 2.90185124 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.86107158 |
| 31 | Heart block (HP:0012722) | 2.85781413 |
| 32 | Atrioventricular block (HP:0001678) | 2.82531808 |
| 33 | Lipoatrophy (HP:0100578) | 2.78380665 |
| 34 | Abnormal atrioventricular conduction (HP:0005150) | 2.71143823 |
| 35 | Deep venous thrombosis (HP:0002625) | 2.70128181 |
| 36 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.58971610 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 2.56626101 |
| 38 | Dilated cardiomyopathy (HP:0001644) | 2.54517217 |
| 39 | Ketoacidosis (HP:0001993) | 2.52194365 |
| 40 | Difficulty climbing stairs (HP:0003551) | 2.51599183 |
| 41 | Obstructive sleep apnea (HP:0002870) | 2.51243278 |
| 42 | Bulbar palsy (HP:0001283) | 2.47515295 |
| 43 | Ketosis (HP:0001946) | 2.43355507 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.42664748 |
| 45 | Calcaneovalgus deformity (HP:0001848) | 2.38369059 |
| 46 | Palpitations (HP:0001962) | 2.37606542 |
| 47 | Malignant hyperthermia (HP:0002047) | 2.37286332 |
| 48 | Rimmed vacuoles (HP:0003805) | 2.34798512 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.32750598 |
| 50 | Myotonia (HP:0002486) | 2.32545417 |
| 51 | Nemaline bodies (HP:0003798) | 2.29451473 |
| 52 | Xanthomatosis (HP:0000991) | 2.28388127 |
| 53 | EMG: neuropathic changes (HP:0003445) | 2.26695630 |
| 54 | Abnormal EKG (HP:0003115) | 2.26029552 |
| 55 | Lower limb amyotrophy (HP:0007210) | 2.25144312 |
| 56 | Scapular winging (HP:0003691) | 2.24256590 |
| 57 | Round ear (HP:0100830) | 2.21552159 |
| 58 | Areflexia of lower limbs (HP:0002522) | 2.20359508 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.15504186 |
| 60 | Lymphangioma (HP:0100764) | 2.14362779 |
| 61 | Intrahepatic cholestasis (HP:0001406) | 2.12937275 |
| 62 | Dysmetric saccades (HP:0000641) | 2.12287368 |
| 63 | Frequent falls (HP:0002359) | 2.06825814 |
| 64 | Gout (HP:0001997) | 2.03343886 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00731810 |
| 66 | Broad metatarsal (HP:0001783) | 2.00063532 |
| 67 | Absent phalangeal crease (HP:0006109) | 1.98879744 |
| 68 | Gowers sign (HP:0003391) | 1.97115511 |
| 69 | Deformed tarsal bones (HP:0008119) | 1.96860505 |
| 70 | Hyperkalemia (HP:0002153) | 1.95698484 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 1.92979436 |
| 72 | Sudden cardiac death (HP:0001645) | 1.92083792 |
| 73 | Muscle stiffness (HP:0003552) | 1.88843602 |
| 74 | Easy fatigability (HP:0003388) | 1.87317977 |
| 75 | Abnormality of the calcaneus (HP:0008364) | 1.86515259 |
| 76 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86216125 |
| 77 | Limb-girdle muscle atrophy (HP:0003797) | 1.86001442 |
| 78 | Facial diplegia (HP:0001349) | 1.85397453 |
| 79 | Hypoalphalipoproteinemia (HP:0003233) | 1.84817586 |
| 80 | Cholelithiasis (HP:0001081) | 1.84710590 |
| 81 | Generalized muscle weakness (HP:0003324) | 1.82638995 |
| 82 | Neck muscle weakness (HP:0000467) | 1.82569035 |
| 83 | Myopathic facies (HP:0002058) | 1.82233302 |
| 84 | Hyperammonemia (HP:0001987) | 1.82122994 |
| 85 | Rhabdomyolysis (HP:0003201) | 1.81794002 |
| 86 | Distal upper limb amyotrophy (HP:0007149) | 1.81278422 |
| 87 | Upper limb amyotrophy (HP:0009129) | 1.81278422 |
| 88 | Hypoplastic ischia (HP:0003175) | 1.81247101 |
| 89 | Hamartoma of the eye (HP:0010568) | 1.80312713 |
| 90 | Abnormality of the foot musculature (HP:0001436) | 1.78866791 |
| 91 | Distal arthrogryposis (HP:0005684) | 1.76203570 |
| 92 | Slender build (HP:0001533) | 1.75425351 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.74564754 |
| 94 | Spinal rigidity (HP:0003306) | 1.73891967 |
| 95 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.73776542 |
| 96 | Rapidly progressive (HP:0003678) | 1.73460094 |
| 97 | Weak cry (HP:0001612) | 1.73022144 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 1.72890917 |
| 99 | Cerebral aneurysm (HP:0004944) | 1.71241804 |
| 100 | Broad face (HP:0000283) | 1.69157350 |
| 101 | Ragged-red muscle fibers (HP:0003200) | 1.68824256 |
| 102 | Abnormal gallbladder morphology (HP:0012437) | 1.66106757 |
| 103 | Abnormality of the ischium (HP:0003174) | 1.65175938 |
| 104 | Cerebral inclusion bodies (HP:0100314) | 1.65160141 |
| 105 | Palmoplantar keratoderma (HP:0000982) | 1.64764235 |
| 106 | Progressive muscle weakness (HP:0003323) | 1.64022465 |
| 107 | Fatigable weakness (HP:0003473) | 1.63569083 |
| 108 | Abnormality of the neuromuscular junction (HP:0003398) | 1.63569083 |
| 109 | Hip contracture (HP:0003273) | 1.63120813 |
| 110 | Skin nodule (HP:0200036) | 1.62948931 |
| 111 | Hyperacusis (HP:0010780) | 1.61813143 |
| 112 | Epidermoid cyst (HP:0200040) | 1.61106769 |
| 113 | Onion bulb formation (HP:0003383) | 1.59389589 |
| 114 | Achilles tendon contracture (HP:0001771) | 1.59222934 |
| 115 | Myokymia (HP:0002411) | 1.58884562 |
| 116 | Waddling gait (HP:0002515) | 1.58604666 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.58525071 |
| 118 | Visceral angiomatosis (HP:0100761) | 1.57883953 |
| 119 | Complement deficiency (HP:0004431) | 1.57773256 |
| 120 | Late onset (HP:0003584) | 1.57656187 |
| 121 | Fetal akinesia sequence (HP:0001989) | 1.57088147 |
| 122 | Ankle clonus (HP:0011448) | 1.56651234 |
| 123 | Hyperglycinuria (HP:0003108) | 1.56249026 |
| 124 | Increased IgE level (HP:0003212) | 1.56141384 |
| 125 | Abnormality of the fingertips (HP:0001211) | 1.55941955 |
| 126 | Stridor (HP:0010307) | 1.55867294 |
| 127 | Abnormal finger flexion creases (HP:0006143) | 1.54257061 |
| 128 | Aneurysm (HP:0002617) | 1.50257292 |
| 129 | Colitis (HP:0002583) | 1.49471757 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.47874401 |
| 131 | Abnormality of complement system (HP:0005339) | 1.47508828 |
| 132 | Eczematoid dermatitis (HP:0000976) | 1.47318008 |
| 133 | Muscular dystrophy (HP:0003560) | 1.43941787 |
| 134 | Cellulitis (HP:0100658) | 1.40591337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.38379359 |
| 2 | TTN | 3.11852853 |
| 3 | OBSCN | 2.75999285 |
| 4 | PKN2 | 2.66681203 |
| 5 | LMTK2 | 2.64942955 |
| 6 | PRPF4B | 2.63742838 |
| 7 | PHKG2 | 2.57248013 |
| 8 | PHKG1 | 2.57248013 |
| 9 | RIPK1 | 2.19362288 |
| 10 | DMPK | 2.08075194 |
| 11 | MAP2K3 | 1.99389617 |
| 12 | CDK12 | 1.83313245 |
| 13 | SIK1 | 1.76284497 |
| 14 | EPHB1 | 1.74364676 |
| 15 | MAP3K7 | 1.72746319 |
| 16 | MAP3K13 | 1.65797065 |
| 17 | PTK6 | 1.65274852 |
| 18 | EPHA4 | 1.53103282 |
| 19 | PAK6 | 1.51435418 |
| 20 | ICK | 1.49171147 |
| 21 | PDGFRA | 1.46216848 |
| 22 | PRKD3 | 1.41708472 |
| 23 | PAK3 | 1.36655274 |
| 24 | RIPK4 | 1.35915999 |
| 25 | DAPK2 | 1.28022496 |
| 26 | WNK4 | 1.21824227 |
| 27 | MAP4K1 | 1.18788905 |
| 28 | TRPM7 | 1.17446685 |
| 29 | TIE1 | 1.16227000 |
| 30 | MAP3K9 | 1.15791232 |
| 31 | BCKDK | 1.14738510 |
| 32 | MAP3K10 | 1.13885340 |
| 33 | ERN1 | 1.12076930 |
| 34 | TNK2 | 1.11001261 |
| 35 | INSRR | 1.10357796 |
| 36 | EPHB2 | 1.09881908 |
| 37 | FGFR4 | 1.09480649 |
| 38 | SMG1 | 1.09232512 |
| 39 | PRKD1 | 1.09081372 |
| 40 | CAMK1G | 1.07846312 |
| 41 | PIK3CA | 1.07664893 |
| 42 | KSR2 | 1.07608279 |
| 43 | ZAP70 | 1.03663261 |
| 44 | MAP3K6 | 1.03067832 |
| 45 | MAPK7 | 1.00060559 |
| 46 | TYRO3 | 0.98864241 |
| 47 | CDC42BPA | 0.98096962 |
| 48 | STK38 | 0.97969576 |
| 49 | CAMKK1 | 0.97908129 |
| 50 | RET | 0.97317008 |
| 51 | PRKCH | 0.97095360 |
| 52 | PKN1 | 0.94873774 |
| 53 | TAOK1 | 0.94616736 |
| 54 | MYLK | 0.93597666 |
| 55 | NTRK1 | 0.93411252 |
| 56 | FER | 0.93132733 |
| 57 | ROCK1 | 0.92815280 |
| 58 | MAP3K2 | 0.92374650 |
| 59 | MAPK11 | 0.92358337 |
| 60 | MARK1 | 0.89861041 |
| 61 | SGK3 | 0.88200872 |
| 62 | WNK1 | 0.87861532 |
| 63 | MAPK12 | 0.87273470 |
| 64 | FGFR2 | 0.87014155 |
| 65 | TBK1 | 0.86174969 |
| 66 | CAMK1D | 0.85720593 |
| 67 | BLK | 0.85089850 |
| 68 | FES | 0.84947889 |
| 69 | PDK3 | 0.83569209 |
| 70 | PDK4 | 0.83569209 |
| 71 | MAP2K4 | 0.83232593 |
| 72 | SIK2 | 0.83199640 |
| 73 | LATS1 | 0.82536967 |
| 74 | PDPK1 | 0.82479662 |
| 75 | MARK2 | 0.80078001 |
| 76 | PRKAA1 | 0.79545054 |
| 77 | PINK1 | 0.79341479 |
| 78 | STK39 | 0.79273598 |
| 79 | MUSK | 0.78588245 |
| 80 | PRKAA2 | 0.78385959 |
| 81 | PTK2 | 0.78202660 |
| 82 | STK11 | 0.77693252 |
| 83 | MAPKAPK3 | 0.74989277 |
| 84 | NEK1 | 0.73697249 |
| 85 | MAP2K6 | 0.73380532 |
| 86 | RPS6KA2 | 0.73188819 |
| 87 | MOS | 0.72518200 |
| 88 | PDGFRB | 0.71698310 |
| 89 | DYRK1B | 0.68293796 |
| 90 | HIPK2 | 0.67975673 |
| 91 | NTRK3 | 0.67132101 |
| 92 | CSF1R | 0.66595497 |
| 93 | CDK5 | 0.65969186 |
| 94 | ROCK2 | 0.65693557 |
| 95 | ERBB2 | 0.65346341 |
| 96 | TYK2 | 0.65335488 |
| 97 | MAP3K1 | 0.64419791 |
| 98 | MAPK4 | 0.64257689 |
| 99 | PTK2B | 0.63762485 |
| 100 | RPS6KC1 | 0.63299268 |
| 101 | RPS6KL1 | 0.63299268 |
| 102 | OXSR1 | 0.62593171 |
| 103 | MTOR | 0.62564258 |
| 104 | MAP3K3 | 0.62502581 |
| 105 | CAMK4 | 0.62268268 |
| 106 | PDK1 | 0.62116757 |
| 107 | CAMK2D | 0.61398588 |
| 108 | BMX | 0.60543076 |
| 109 | SGK223 | 0.60369756 |
| 110 | SGK494 | 0.60369756 |
| 111 | BTK | 0.59501618 |
| 112 | UHMK1 | 0.57761722 |
| 113 | NEK9 | 0.57345497 |
| 114 | SYK | 0.57315474 |
| 115 | MAP3K4 | 0.56794018 |
| 116 | EEF2K | 0.56266291 |
| 117 | SGK2 | 0.55901119 |
| 118 | MAP3K11 | 0.55741399 |
| 119 | MAP2K1 | 0.55224762 |
| 120 | CAMK1 | 0.53797601 |
| 121 | MET | 0.52754469 |
| 122 | HCK | 0.51782865 |
| 123 | SGK1 | 0.51549807 |
| 124 | ILK | 0.50466680 |
| 125 | ALK | 0.50220803 |
| 126 | NTRK2 | 0.49650612 |
| 127 | PIK3CG | 0.49328921 |
| 128 | MAPK10 | 0.49266482 |
| 129 | DAPK3 | 0.49150119 |
| 130 | JAK1 | 0.48937129 |
| 131 | MAP3K14 | 0.48299449 |
| 132 | PRKD2 | 0.47901702 |
| 133 | FGFR3 | 0.47355961 |
| 134 | TGFBR2 | 0.47299893 |
| 135 | RPS6KA6 | 0.46307567 |
| 136 | JAK2 | 0.46117716 |
| 137 | KIT | 0.46088386 |
| 138 | LATS2 | 0.45810935 |
| 139 | MST1R | 0.44584096 |
| 140 | CAMK2G | 0.43655583 |
| 141 | IRAK3 | 0.43307306 |
| 142 | TAOK2 | 0.40712669 |
| 143 | MAP2K2 | 0.40397732 |
| 144 | ITK | 0.38621021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86935269 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78672893 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.21814242 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06950141 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05476843 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.03190426 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.98088101 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.85069111 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.81924823 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66015984 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.65314169 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65302388 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.64659899 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63903409 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59336434 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54238486 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47590192 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45490947 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42128847 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39332234 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38113408 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.37927283 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36365627 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.29621397 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28100926 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24255092 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22055555 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20450439 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.17283151 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14803016 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13527534 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11769133 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10451442 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10364826 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08205211 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06932614 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.06378726 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.05820000 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05623097 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05373767 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05124490 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04307144 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00735340 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00405411 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.00237926 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97656192 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96910636 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93980601 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93315972 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.92349060 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91787200 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91773679 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90427317 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 0.89202469 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87296916 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85926449 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85644209 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85231547 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85043922 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84805464 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83731081 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83650446 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.83106307 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.82894278 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82705829 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82111775 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82085390 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82082086 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81270080 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81210673 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81199345 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79860741 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79624372 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79471469 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78033101 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.77618477 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75306505 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75204619 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.74725442 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73770313 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71153844 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71045512 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69406039 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69297980 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68001312 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67204974 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66999905 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66776602 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65314034 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63874422 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63640361 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.63390662 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63230604 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.62147712 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61519473 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61456041 |
| 97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60698831 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60315967 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60294576 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59971971 |
| 101 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59658884 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.59493851 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59297753 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59059591 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58222607 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57543865 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56262255 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56142918 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.56092833 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56070382 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56065115 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55517034 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55239271 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.54217521 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54012360 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.53109868 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52467108 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51925495 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51913795 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51522285 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51355678 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.51150554 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50622897 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50578896 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50377773 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49419645 |
| 127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48683470 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48509427 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.48397070 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47986666 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47826005 |
| 132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47721604 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47499585 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.47299202 |
| 135 | Glioma_Homo sapiens_hsa05214 | 0.46997931 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44920187 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44571577 |
| 138 | Morphine addiction_Homo sapiens_hsa05032 | 0.44049962 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43037517 |
| 140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42519936 |
| 141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42263030 |
| 142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40711594 |

